Cambridge Healthtech Institute’s 10th Annual

Preclinical Strategies and Models in Oncology

September 29-30, 2021

 

The rise of cancer immunotherapy instigated unique preclinical and translational challenges. In addition to immuno-oncology advances, we are witnessing a new wave of targeted and novel therapies that enrich the arsenal of combination cancer therapies. The demand for predictive and robust preclinical models and approaches to minimize translational failures in oncology and immuno-oncology is at an all-time high. The need for leveraging phenotypic features of models, for early identification of predictive biomarkers, for rational design of combination therapies, and for researching the cancer-immune cell interactions adds to the complexity of translational research in oncology and immuno-oncology. Cambridge Healthtech Institute’s 10th Annual Preclinical Strategies and Models in Oncology conference is designed as a forum for ideas and opinions exchange on how to decrease the rate of translational and clinical failures in oncology and immuno-oncology.

 

Who should attend: Scientists and executives working in preclinical oncology and immuno-oncology departments.

 

Coverage will include, but is not limited to:

 

  • Reverse translation to guide combination strategies
  • Next-generation modeling systems
  • Specific challenges and solutions in translational immuno-oncology
  • Leveraging Artificial Intelligence in preclinical oncology
  • Rational design of  combination therapies
  • New targets and approaches in oncology
  • Immunocompetent models for preclinical immuno-oncology research
  • Models for CAR T therapy
  • Application of humanized and syngeneic models: case studies
  • Preclinical and translational imaging
  • Integrating in vivo and in vitro modeling
  • Modeling for tumor stroma research
  • Human tumor organoids

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is March 29, 2021.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:

Marina Filshtinsky, MD

Executive Producer, Conferences

Cambridge Healthtech Institute

Phone: (+1) 781-972-5496

Email: mfilshtinsky@healthtech.com

 

For partnering and sponsorship information, please contact:

Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286

Email: reymael@healthtech.com


Submit a Speaker Proposal